A. Bergami

发表

Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia

G. Martino, F. Ruffini, R. Furlan, 2012, Gene Therapy.

In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat

M. Gobbi, S. Garattini, E. Frittoli, 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism

G. Comi, G. Martino, S. Pluchino, 2005, Nature.

Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.

M. Su, G. Comi, R. Flavell, 1999, Journal of immunology.

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles

G. Comi, G. Magnani, G. Legname, 2013, Cell Death and Differentiation.

Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia

S. Perrotta, M. Lidonnici, S. Galimberti, 2019, Nature Medicine.

Effect ofd-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymes

S. Garattini, S. Caccia, A. Bergami, 1995, Psychopharmacology.

AutoimmunityInfiltrate the Target Tissue in Experimental T Cells + Secreting Foxp3 - g and IFN- - IL-17

G. Martino, G. Borsellino, F. Ruffini, 2010 .

IL-17– and IFN-γ–Secreting Foxp3+ T Cells Infiltrate the Target Tissue in Experimental Autoimmunity

G. Martino, G. Borsellino, F. Ruffini, 2010, The Journal of Immunology.

Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice

G. Comi, G. Martino, F. Ruffini, 2001, Gene Therapy.

Immunological markers in multiple sclerosis

G. Comi, G. Martino, F. Ruffini, 2000, Neurological Sciences.

Detection of TNF and TNF receptor mRNA in cells and tissues.

G. Martino, R. Furlan, A. Bergami, 2004, Methods in molecular medicine.

A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis

E. Ongini, G. Comi, G. Martino, 2004, Journal of Neuroimmunology.

Caspase-1 levels in biological fluids from patients with multiple sclerosis and from patients with other neurological and non-neurological diseases.

R. Bergamaschi, G. Martino, R. Furlan, 2002, European cytokine network.

Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.

M. Rovaris, G. Comi, G. Martino, 2001, Human gene therapy.

HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35–55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice

G. Comi, G. Martino, R. Furlan, 2007, Gene Therapy.

Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates

G. Comi, G. Martino, R. Furlan, 2008, Gene Therapy.

Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.

G. Comi, L. Grimaldi, G. Martino, 1998, Human gene therapy.

Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss

G. Comi, G. Martino, F. Ruffini, 2009, Journal of Neuroimmunology.

Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice

R. Furlan, M. Teixeira, A. Bergami, 2016, Journal of Neuroimmune Pharmacology.

Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4.

G. Comi, P. Panina, G. Martino, 2000, Journal of neuroimmunology.

The effect of the spin trapping agent α-phenyl-n-tert-butyl nitrone on dexfenfluramine-induced serotonin depletion in rat brain.

S. Caccia, A. Bergami, C. Fracasso, 1997, Environmental toxicology and pharmacology.

Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia

S. Perrotta, M. Lidonnici, S. Galimberti, 2019, Nature Medicine.

Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis

M. Trojano, G. Martino, P. Livrea, 2012, Journal of Neuroimmunology.

Myeloid microvesicles are a marker and therapeutic target for neuroinflammation

A. Vercelli, M. Rocca, M. Francolini, 2012, Annals of neurology.

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis

Angelo L. Vescovi, Angelo Quattrini, Giancarlo Comi, 2003, Nature.

The role of proinflammatory cytokines in multiple sclerosis

G. Martino, R. Furlan, A. Bergami, 1999 .

Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis

D. Centonze, G. Bernardi, G. Comi, 2009, The Journal of Neuroscience.

Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration

D. Centonze, G. Martino, F. Barbieri, 2014, Multiple sclerosis.

Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia

M. Bellani, G. Rambaldelli, M. Tansella, 2014, Translational Psychiatry.

Intrathecal Delivery of IFN-γ Protects C57BL/6 Mice from Chronic-Progressive Experimental Autoimmune Encephalomyelitis by Increasing Apoptosis of Central Nervous System-Infiltrating Lymphocytes1

G. Comi, G. Martino, F. Ruffini, 2001, The Journal of Immunology.

Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing–remitting autoimmune encephalomyelitis in Biozzi AB/H mice

G. Comi, G. Martino, F. Ruffini, 2001, Gene Therapy.

Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study

M. Filippi, M. Rocca, G. Comi, 1999, Journal of neurology, neurosurgery, and psychiatry.

Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice.

G. Comi, L. Roccatagliata, G. Martino, 2003, Brain : a journal of neurology.

Activation of invariant NKT cells by αGalCer administration protects mice from MOG35–55‐induced EAE: critical roles for administration route and IFN‐γ

G. Martino, R. Furlan, P. Dellabona, 2003 .

Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4

G. Comi, P. Panina, G. Martino, 2000, Journal of Neuroimmunology.

Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis

G. Comi, G. Martino, R. Furlan, 2010, Molecular and Cellular Neuroscience.

Cytokines and immunity in multiple sclerosis: the dual signal hypothesis

G. Comi, L. Grimaldi, G. Martino, 2000, Journal of Neuroimmunology.

Central Nervous System Delivery of Interleukin 4 by a Nonreplicative Herpes Simplex Type 1 Viral Vector Ameliorates Autoimmune Demyelination

G. Comi, L. Grimaldi, G. Martino, 1998 .

A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines

G. Comi, L. Grimaldi, G. Martino, 1998, Multiple sclerosis.

Vaccination with amyloid-b peptide induces autoimmune encephalomyelitis in C 57 / BL 6 mice

G. Comi, L. Roccatagliata, G. Martino, 2022 .

Growth Factors and Synaptic Plasticity in Relapsing–Remitting Multiple Sclerosis

D. Centonze, G. Martino, F. Barbieri, 2014, NeuroMolecular Medicine.

Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis

D. Centonze, N. Mercuri, G. Martino, 2013, The Journal of Neuroscience.

Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis

D. Centonze, N. Mercuri, N. Berretta, 2014, NeuroMolecular Medicine.

Interleukin‐1β causes synaptic hyperexcitability in multiple sclerosis

D. Centonze, G. Bernardi, G. Martino, 2012, Annals of neurology.

Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents.

M. Rovaris, M. Filippi, M. Rocca, 1999, Magnetic resonance imaging.

Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease

F. Agosta, G. Comi, G. Magnani, 2014, Annals of neurology.

Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs

A. Sica, G. Comi, C. Farina, 2014, Journal of leukocyte biology.

IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis

G. Comi, G. Martino, S. Pluchino, 2008, Gene Therapy.

T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients

D. Centonze, V. Martinelli, G. Comi, 2011, PloS one.

Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis

D. Centonze, G. Bernardi, G. Sancesario, 2011, Multiple sclerosis.

Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.

G. Martino, R. Furlan, P. Dellabona, 2003, European journal of immunology.

Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat

S. Garattini, S. Caccia, A. Bergami, 1995, Neuropharmacology.

Neuropharmacological Effects of Low and High Doses of Repeated Oral Dexfenfluramine in Rats: A Comparison with Fluoxetine

S. Garattini, S. Caccia, A. Bergami, 1997, Pharmacology Biochemistry and Behavior.

Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brain

M. Gobbi, S. Caccia, A. Bergami, 1996, Neuroscience Letters.

Immunological patterns identifying disease course and evolution in multiple sclerosis patients

M. Rovaris, M. Filippi, F. Agosta, 2005, Journal of Neuroimmunology.

Pharmacokinetics of Isosorbide Dinitrate in Healthy Volunteers After 24‐Hour Intravenous Infusion

R. Latini, R. Urso, S. Caccia, 1997, Journal of clinical pharmacology.

TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis.

C. Tinelli, G. Martino, A. Bergami, 1999, Clinical chemistry.

Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates.

S Garattini, S. Garattini, S. Caccia, 1995, Xenobiotica; the fate of foreign compounds in biological systems.

Brain Uptake and Acute Indole‐depleting Effect of Dexfenfluramine in Squirrel Monkeys after a High‐dose Regimen

S. Garattini, S. Caccia, A. Bergami, 1995 .

Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease

F. Agosta, G. Comi, G. Magnani, 2014, Annals of neurology.

Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss

G. Comi, F. Ruffini, R. Furlan, 2009, Journal of Neuroimmunology.

Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice

R. Furlan, M. Teixeira, A. Bergami, 2015, Journal of Neuroimmune Pharmacology.

IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis

G. Comi, S. Pluchino, R. Furlan, 2008, Gene Therapy.

Effect of extracellular vesicles derived from distinct brain cells on Aβ toxicity and assembly: focus on Microglia derived vesicles

G. Comi, G. Magnani, G. Legname, 2015, SpringerPlus.